Caris Life Sciences Stock

carislifesciences.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $465MM

Operator of a biotechnology company specializing in cancer treatment agents. The company is a provider of molecular science focused on fulfilling the promise of precision medicine and facilitating a deeper understanding of cancer biology and other complex diseases through a suite of molecular profiling offerings assess DNA, RNA and proteins that reveal the molecular blueprint, enabling physicians and cancer patients to make more precise and personalized treatment decisions.

Register for Details

For more details on financing and valuation for Caris Life Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Caris Life Sciences.

Register Today

Team

Management Team

David Halbert
Co-Founder, Chairman and Chief Executive Officer
Ginger Appleberry JD
Chief Compliance Officer & Associate General Counsel
Brian Lamon Ph.D
Chief Business Officer & Head of BioPharma Business Development
Thomas Parker
Chief Financial Officer and Senior Vice President
Ronald Merlino
Senior Vice President & Chief Information Officer
Jim Abraham
Chief Data Officer & Senior Vice President
David Spetzler Ph.D
President & Chief Scientific Officer
Stephanie Thomas
Chief of Staff, Executive Vice President & Office of the CEO

Board Members

Peter Castleman
J.H. Whitney Capital Partners
Vijay Mohan
Sixth Street Specialty Lending

Other companies like Caris Life Sciences in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Caris' Precision Oncology Alliance Welcomes the OU Health Stephenson Cancer Center
OU Health Stephenson Cancer Center joins Caris' extensive network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes
In Brief This Week: Illumina, Caris Life Sciences, Fresenius Medical Care, More
News items for the week of April 11, 2022.
In Brief This Week: Ginkgo Bioworks, Caris Life Sciences, MDxHealth, and More
News items for the week of Oct. 25, 2021.
Updated on: Sep 20, 2023